343 related articles for article (PubMed ID: 24475071)
1. Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.
Gupta R; Kumar V; Kushawaha PK; Tripathi CP; Joshi S; Sahasrabuddhe AA; Mitra K; Sundar S; Siddiqi MI; Dube A
PLoS One; 2014; 9(1):e86073. PubMed ID: 24475071
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.
Khare P; Jaiswal AK; Tripathi CD; Joshi S; Sundar S; Dube A
Parasitol Res; 2014 Mar; 113(3):851-62. PubMed ID: 24370734
[TBL] [Abstract][Full Text] [Related]
3. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
Tandon R; Chandra S; Baharia RK; Misra P; Das S; Rawat K; Siddiqi MI; Sundar S; Dube A
Parasitology; 2018 Apr; 145(4):508-526. PubMed ID: 28691653
[TBL] [Abstract][Full Text] [Related]
4. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
Khare P; Jaiswal AK; Tripathi CD; Sundar S; Dube A
Clin Exp Immunol; 2016 Aug; 185(2):165-79. PubMed ID: 26898994
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
Kushawaha PK; Gupta R; Tripathi CD; Sundar S; Dube A
PLoS One; 2012; 7(4):e35670. PubMed ID: 22539989
[TBL] [Abstract][Full Text] [Related]
6. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
7. Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
Jaiswal AK; Khare P; Joshi S; Kushawaha PK; Sundar S; Dube A
PLoS One; 2014; 9(9):e108556. PubMed ID: 25268700
[TBL] [Abstract][Full Text] [Related]
8. A Chimera of Th1 Stimulatory Proteins of
Ratnapriya S; Keerti ; Yadav NK; Dube A; Sahasrabuddhe AA
Biomed Res Int; 2021; 2021():8845826. PubMed ID: 34095312
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model.
Anand A; Balodi DC; Ramalingam K; Yadav S; Goyal N
Mol Immunol; 2022 Jan; 141():33-42. PubMed ID: 34798496
[TBL] [Abstract][Full Text] [Related]
10. Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.
Baharia RK; Tandon R; Sharma T; Suthar MK; Das S; Siddiqi MI; Saxena JK; Sundar S; Dube A
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003557. PubMed ID: 25745863
[TBL] [Abstract][Full Text] [Related]
11. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
[TBL] [Abstract][Full Text] [Related]
12. A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis.
Gupta R; Kushawaha PK; Tripathi CD; Sundar S; Dube A
Int J Parasitol; 2012 May; 42(5):429-35. PubMed ID: 22502587
[TBL] [Abstract][Full Text] [Related]
13. Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.
Baharia RK; Tandon R; Sahasrabuddhe AA; Sundar S; Dube A
PLoS One; 2014; 9(6):e97911. PubMed ID: 24926878
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.
Kushawaha PK; Gupta R; Tripathi CD; Khare P; Jaiswal AK; Sundar S; Dube A
PLoS One; 2012; 7(9):e45766. PubMed ID: 23049855
[TBL] [Abstract][Full Text] [Related]
15. Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.
Jaiswal AK; Khare P; Joshi S; Rawat K; Yadav N; Sundar S; Dube A
Parasitology; 2015 Apr; 142(5):728-44. PubMed ID: 25498563
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of
Joshi S; Yadav NK; Rawat K; Kumar V; Ali R; Sahasrabuddhe AA; Siddiqi MI; Haq W; Sundar S; Dube A
Front Immunol; 2019; 10():288. PubMed ID: 30873164
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
Das P; Paik D; Naskar K; Chakraborti T
Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
[TBL] [Abstract][Full Text] [Related]
18. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
Basu R; Bhaumik S; Basu JM; Naskar K; De T; Roy S
J Immunol; 2005 Jun; 174(11):7160-71. PubMed ID: 15905560
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis.
Keerti ; Yadav NK; Joshi S; Ratnapriya S; Sahasrabuddhe AA; Dube A
Vaccine; 2018 Apr; 36(17):2293-2299. PubMed ID: 29573875
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes.
Amit A; Dikhit MR; Mahantesh V; Chaudhary R; Singh AK; Singh A; Singh SK; Das VN; Pandey K; Ali V; Narayan S; Sahoo GC; Das P; Bimal S
J Biomol Struct Dyn; 2017 Jan; 35(1):128-140. PubMed ID: 26727289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]